(4502) - FDA

(4502) – FDA

Apr 18, 2024 07:08 PM Takeda (TAK) U.S. FDA Approves Subcutaneous Administration of ENTYVIO
Mar 19, 2024 12:20 PM Takeda (TAK) Announces U.S. FDA Approval of sNDA for ICLUSIG in Adult Patients with Newly Diagnosed Ph+ ALL
Jan 29, 2024 11:10 AM
Nov 7, 2023 10:00 AM
Oct 2, 2023 04:35 PM
Apr 27, 2023 08:03 AM
Dec 13, 2022 07:02 AM
Nov 22, 2022 03:57 PM
Oct 5, 2022 08:10 AM
Dec 21, 2021 05:00 PM
Nov 23, 2021 05:26 PM
Sep 15, 2021 04:41 PM
Jul 28, 2021 08:18 AM
May 21, 2021 06:18 AM
Mar 25, 2021 04:21 PM
Mar 15, 2021 09:10 AM
Mar 15, 2021 07:32 AM
Mar 12, 2021 06:29 AM
Mar 5, 2021 06:35 AM
Mar 3, 2021 07:05 AM
Jan 28, 2021 02:44 PM
Jan 21, 2021 09:00 AM
Dec 4, 2020 06:26 AM
Sep 18, 2020 06:56 AM
Aug 28, 2020 06:20 AM
Aug 25, 2020 07:14 AM
Aug 7, 2020 06:18 AM
Jul 30, 2020 06:57 AM
Jun 16, 2020 07:02 AM
Jun 12, 2020 08:04 AM
May 29, 2020 08:04 AM
May 29, 2020 08:04 AM
May 29, 2020 08:03 AM
May 22, 2020 04:31 PM
May 14, 2020 08:07 AM
Apr 27, 2020 08:05 AM
Apr 6, 2020 08:03 AM
Mar 31, 2020 08:10 AM
Mar 10, 2020 08:01 AM
Dec 9, 2019 10:03 AM
Nov 25, 2019 08:41 AM
Nov 6, 2019 05:28 PM
Oct 28, 2019 09:10 AM
Sep 25, 2019 05:02 PM
Sep 24, 2019 07:06 AM
Jun 5, 2019 05:08 PM
Feb 11, 2019 08:08 AM
Oct 1, 2018 06:48 AM
Jan 17, 2018 07:10 AM
Jan 5, 2018 07:05 AM